(NASDAQ: EYEN) Eyenovia's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.
Eyenovia's earnings in 2025 is -$49,818,433.On average, 1 Wall Street analyst forecast EYEN's earnings for 2025 to be -$45,713,318, with the lowest EYEN earnings forecast at -$45,713,318, and the highest EYEN earnings forecast at -$45,713,318. On average, 1 Wall Street analyst forecast EYEN's earnings for 2026 to be -$40,759,862, with the lowest EYEN earnings forecast at -$40,759,862, and the highest EYEN earnings forecast at -$40,759,862.
In 2027, EYEN is forecast to generate -$30,711,424 in earnings, with the lowest earnings forecast at -$30,711,424 and the highest earnings forecast at -$30,711,424.